Compare ZBH & LII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZBH | LII |
|---|---|---|
| Founded | 1927 | 1895 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.5B | 19.5B |
| IPO Year | 2001 | 1999 |
| Metric | ZBH | LII |
|---|---|---|
| Price | $86.09 | $477.28 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 19 | 12 |
| Target Price | $104.76 | ★ $582.82 |
| AVG Volume (30 Days) | ★ 1.8M | 356.5K |
| Earning Date | 05-04-2026 | 04-22-2026 |
| Dividend Yield | 1.09% | ★ 1.11% |
| EPS Growth | N/A | ★ 1.11 |
| EPS | 3.55 | ★ 22.79 |
| Revenue | ★ $8,231,500,000.00 | $5,195,300,000.00 |
| Revenue This Year | $4.93 | $6.89 |
| Revenue Next Year | $3.72 | $5.74 |
| P/E Ratio | $24.88 | ★ $20.60 |
| Revenue Growth | ★ 7.20 | N/A |
| 52 Week Low | $84.59 | $443.19 |
| 52 Week High | $114.44 | $689.44 |
| Indicator | ZBH | LII |
|---|---|---|
| Relative Strength Index (RSI) | 30.61 | 35.72 |
| Support Level | $85.23 | $443.19 |
| Resistance Level | $96.45 | $571.67 |
| Average True Range (ATR) | 2.50 | 15.57 |
| MACD | -1.03 | -4.13 |
| Stochastic Oscillator | 0.27 | 16.66 |
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
Lennox International manufacturers and distributes heating, ventilating, air conditioning, and refrigeration products for the North American replacement (75% of sales) and new construction (25% of sales) markets. Residential HVAC (home comfort solutions) accounted for 67% of sales and commercial HVAC (building climate solutions) accounted for the remaining 33% of sales. To be clear, Lennox's commercial exposure is what its peers refer to as "residential and light commercial," lacks the scale and complexity of what is referred to as an "applied" solution. The company goes to market with multiple brands, but Lennox is the company's flagship HVAC brand.